Fibrinolytic assays in bleeding of unknown cause: Improvement in diagnostic yield.

Valke, Lars L F G; Meijer, Danielle; Nieuwenhuizen, Laurens; Laros-van Gorkom, Britta A P; Blijlevens, Nicole M A; van Heerde, Waander L; Schols, Saskia E M

Valke, Lars L F G; Meijer, Danielle; Nieuwenhuizen, Laurens; Laros-van Gorkom, Britta A P; Blijlevens, Nicole M A; van Heerde, Waander L; Schols, Saskia E M.

Valke LLFG; Department of Hematology Radboud University Medical Center Nijmegen The Netherlands.
Meijer D; Hemophilia Treatment Center Nijmegen-Eindhoven-Maastricht The Netherlands.
Nieuwenhuizen L; Department of Laboratory Medicine Laboratory of Hematology Radboud University Medical Center Nijmegen The Netherlands.
Laros-van Gorkom BAP; Hemophilia Treatment Center Nijmegen-Eindhoven-Maastricht The Netherlands.
Blijlevens NMA; Department of Hematology Maxima Medical Center Veldhoven The Netherlands.
van Heerde WL; Department of Hematology Radboud University Medical Center Nijmegen The Netherlands.
Schols SEM; Hemophilia Treatment Center Nijmegen-Eindhoven-Maastricht The Netherlands.

Res Pract Thromb Haemost ; 6(2): e12681, 2022 Feb.

Article en En | MEDLINE | ID: mdl-35316940

Palabras clave

bleeding of unknown cause; fibrin clot lysis time; fibrinolysis; plasminogen activator inhibitor 1; tissue plasminogen activator; tranexamic acid

Texto completo

Imprimir

XML

PubMed Links

Search on Google

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Diagnostic_studies / Observational_studies Idioma: En Año: 2022 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Search on Google

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Diagnostic_studies / Observational_studies Idioma: En Año: 2022 Tipo del documento: Article